VKTX - バイキング・セラピュ―ティクス （Viking Therapeutics Inc.）VKTXのニュース
Why Viking Therapeutics Stock Wobbled Today 2023/05/09 19:40:21 The Motley Fool
The biotech''s shares dipped along with the broader markets in early-morning trading today.
Brinker Capital Investments LLC Makes New $95,000 Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX) 2023/05/09 09:08:47 The AM Reporter
Brinker Capital Investments LLC acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 10,055 shares of the biotechnology company’s stock, valued at approximately $95,000. Other hedge funds also recently added to or […]
Viking Therapeutics off 5% following CEO stock sale 2023/05/02 19:08:37 Seeking Alpha
Viking Therapeutics is down ~5% Tuesday following the disclosure that CEO Brian Lian sold shares. Read more here.
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today 2023/05/01 20:28:20 The Motley Fool
These three biotech stocks were on the volatile side today.
Why Viking Therapeutics Stock Briefly Popped Today | The Motley Fool 2023/04/27 18:56:13 The Motley Fool
The biotech''s shares rose briefly this morning following a sizable price target revision by an investing firm.
Why Viking Therapeutics Stock Briefly Popped Today | The Motley Fool 2023/04/27 18:56:13 The Motley Fool
The biotech''s shares rose briefly this morning following a sizable price target revision by an investing firm.
H.C. Wainwright maintains Viking Therapeutics Inc at Buy with a price target of $33.00 2023/04/27 14:16:37 Investing.com
https://www.investing.com/news/pro/viking-therapeutics-inc-receives-investment-bank-analyst-rating-update-3066478
Viking Therapeutics, Inc. (VKTX) Q1 2023 - Earnings Call Transcript 2023/04/27 00:55:18 Seeking Alpha
Viking Therapeutics, Inc. (NASDAQ:NASDAQ:VKTX) Q1 2023 Earnings Conference Call April 26, 2023 4:30 PM ETCompany ParticipantsStephanie Diaz - Manager of Investor RelationsBrian Lian -…
Viking Therapeutics GAAP EPS of -$0.25 misses by $0.01 2023/04/26 20:08:32 Seeking Alpha
Viking Therapeutics press release (VKTX): Q1 GAAP EPS of -$0.25 misses by $0.01.At March 31, 2023, Viking held cash, cash equivalents and short-term investments of $135.7…
Viking Therapeutics (NASDAQ:VKTX) Price Target Increased to $35.00 by Analysts at Oppenheimer 2023/04/26 08:10:45 The AM Reporter
Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price lifted by Oppenheimer from $30.00 to $35.00 in a report released on Tuesday morning, The Fly reports. A number of other brokerages have also issued reports on VKTX. StockNews.com assumed coverage on shares of Viking Therapeutics in a report on Thursday, March 16th. They issued […]
Why Shares of Viking Therapeutics Skyrocketed This Week 2023/03/30 18:06:33 The Motley Fool
The clinical-stage stock nearly doubled in price.
Thursday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Carnival, Delta Air Lines, First Republic Bank, Lululemon, Macy’s, Marathon Petroleum, Micron Technology and More 2023/03/30 12:55:54 24/7 Wall street
Thursday''s top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic Group, Invesco, Lululemon Athletica, Macy’s, Marathon Petroleum, Medtronic, Micron Technology, Nextracker, Viking Therapeutics and Vipshop.
Viking Therapeutics Prices 17.24M Share Offering at $14.50/sh 2023/03/30 09:55:05 Investing.com
https://www.investing.com/news/assorted/viking-therapeutics-prices-1724m-share-offering-at-1450sh-432SI-3044833
Viking Therapeutics sheds on pricing $250M stock offering 2023/03/30 09:06:37 Seeking Alpha
Viking Therapeutics (VKTX) shares are down 4.27% premarket after the firm has priced its underwritten public offering of 17.24M shares of its common stock at a price to the public…
Viking Therapeutics (NASDAQ:VKTX) Given New $35.00 Price Target at Raymond James 2023/03/30 09:00:41 The AM Reporter
Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price hoisted by Raymond James from $12.00 to $35.00 in a research note published on Wednesday morning, The Fly reports. They currently have an outperform rating on the biotechnology company’s stock. Several other analysts have also issued reports on the stock. Oppenheimer upped their target price […]